Tag Archives: Synuclein Toxicity

CoEN “Pathfinder” Funding for Neurodegenerative Disease Research Announced (MRC)

Summary The Centres of Excellence in Neurodegenerative Disease (CoEN) initiative has awarded £3.6 million to 11 international “Pathfinder” innovation projects. These projects aim to identify and validate new potential drugs and develop innovative therapeutic approaches for the dementia, and other conditions such … Continue reading

Posted in Commissioning, For Researchers (mostly), In the News, International, Models of Dementia Care, Parkinson's Disease, Pharmacological Treatments, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment